Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Syngene International Ltd. ( (IN:SYNGENE) ) has provided an announcement.
Biocon Limited, the promoter of Syngene International Ltd., has submitted a declaration to exchanges and Syngene’s audit committee under Regulation 31(4) of India’s takeover regulations. The filing confirms that Biocon, its promoter group entities and persons acting in concert have not created any encumbrances on the Syngene shares they directly or indirectly hold during or as of the end of the 2025-26 financial year.
The confirmation that promoter and group holdings in Syngene remain unencumbered signals a clean capital structure and may reassure investors about the absence of share pledges or similar obligations. This status supports perceptions of financial stability and governance transparency at the listed research services company and its promoter, which can be significant for minority shareholders and market confidence.
More about Syngene International Ltd.
Syngene International Ltd. operates in the contract research and manufacturing services industry, providing discovery, development and manufacturing services to global pharmaceutical, biotechnology and other life sciences companies. The company plays a key role as a research and development partner, supporting clients across the drug development value chain.
Average Trading Volume: 157,397
Technical Sentiment Signal: Sell
Current Market Cap: 178.7B INR
For a thorough assessment of SYNGENE stock, go to TipRanks’ Stock Analysis page.